NEW YORK, Feb. 21, 2018 -- Wolf Haldenstein Adler Freeman & Herz LLP announces that a federal securities class action lawsuit has been filed in the United States District Court for the District of New Jersey against Riot Blockchain, Inc. (NASDAQ:RIOT) (“Riot”) on behalf of all shareholders who acquired shares from November 13, 2017 through February 15, 2018, both dates inclusive (“Class Period).
Investors who have incurred losses in Riot Blockchain, Inc. are urged to contact the firm immediately at [email protected] or (800) 575-0735 or (212) 545-4774. You may obtain additional information concerning the action on our website, www.whafh.com.
If you have incurred losses in the shares of Riot Blockchain, Inc. and would like to assist with the litigation process as a lead plaintiff, you may, no later than April 18, 2018, request that the Court appoint you lead plaintiff of the proposed class. Please contact Wolf Haldenstein to learn more about your rights as an investor in Riot Blockchain, Inc.
According to the filed lawsuit, defendants throughout the Class Period made false and/or misleading statements and/or failed to disclose that:
- Riot’s principle executive offices were not in Colorado, but rather in Florida in the same location as a large, influential shareholder, Barry C. Honig who had a previous working relationship with Defendant O’Rouke;
- Riot never intended to hold its Annual General Meetings scheduled for December 28, 2017 and February 1, 2018; and
- as a result, Defendants’ statements about Riot’s business, operations and prospects were materially false and misleading and/or lacked a reasonable basis at all relevant times.
Shares of Riot Blockchain, Inc. presently trade close to 80% below the class period high of $46.20 reached on December 19, 2017.
Wolf Haldenstein Adler Freeman & Herz LLP has extensive experience in the prosecution of securities class actions and derivative litigation in state and federal trial and appellate courts across the country. The firm has attorneys in various practice areas; and offices in New York, Chicago and San Diego. The reputation and expertise of this firm in shareholder and other class litigation has been repeatedly recognized by the courts, which have appointed it to major positions in complex securities multi-district and consolidated litigation.
If you wish to discuss this action or have any questions regarding your rights and interests in this case, please immediately contact Wolf Haldenstein by telephone at (800) 575-0735, via e-mail at [email protected], or visit our website at www.whafh.com.
## Follow the firm and learn about newly filed cases on Twitter and Facebook. ##
Contact:
Wolf Haldenstein Adler Freeman & Herz LLP
Kevin Cooper, Esq.
Gregory Stone, Director of Case and Financial Analysis
Email: [email protected], [email protected] or [email protected]
Tel: (800) 575-0735 or (212) 545-4774
Attorney Advertising. Prior results do not guarantee or predict a similar outcome.


Air New Zealand Cabin Crew Strike Set for February 12–13 Amid Failed Talks
Alphabet Plans Rare 100-Year Sterling Bond to Fund AI Expansion
Salesforce Workforce Reduction Affects Fewer Than 1,000 Roles Amid Ongoing Restructuring
Standard Chartered Names Peter Burrill as Interim Group CFO Following Diego De Giorgi’s Exit
Lyft Shares Slide After Weak Q1 Profit Forecast and Surprise 2025 Operating Loss
Canadian Airlines Suspend Cuba Flights Amid Jet Fuel Shortage and U.S. Sanctions
Petrobras Posts Record Oil Exports as Production Surge Fuels Global Expansion
Moderna Stock Drops After FDA Declines Review of mRNA Flu Vaccine
Russia Signals Further Restrictions on Telegram Amid Ongoing Regulatory Disputes
AST SpaceMobile Joins MSCI ACWI Index as Largest New Addition, Boosting Market Visibility
xAI Co-Founder Jimmy Ba Departs as Elon Musk’s AI Startup Faces Turbulence
Ralph Lauren Unveils Elegant Fall 2026 Women’s Collection Ahead of New York Fashion Week
SMIC Shares Slide Despite Strong AI-Driven Earnings as Margin Pressure Looms
ByteDance Advances AI Chip Development With Samsung Manufacturing Talks
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
FDA Rejects Review of Moderna’s Flu Vaccine Application, Shares Slide
Innovent Biologics Shares Rally on New Eli Lilly Oncology and Immunology Deal 



